Cargando…

Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study

The type of pathological response to neoadjuvant chemoradiation in patients with locally advanced esophageal cancer predicts overall survival (OS). We aimed to assess early 18F-FDG positron emission tomography/computed tomography parameters in predicting the pathological response to neoadjuvant trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domachevsky, Liran, Kashtan, Hanoch, Brenner, Baruch, Nidam, Meital, Morgenstern, Sara, Kundel, Yulia, Groshar, David, Bernstine, Hanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310504/ https://www.ncbi.nlm.nih.gov/pubmed/30544419 http://dx.doi.org/10.1097/MD.0000000000013412

Ejemplares similares

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using (18)F-FDG PET-CT imaging: a prospective cohort study
por: Brenner, Baruch, et al.
Publicado: (2022)

Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
por: Groshar, David, et al.
Publicado: (2017)

18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC)
por: Bernstine, Hanna, et al.
Publicado: (2018)

Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability
por: Domachevsky, Liran, et al.
Publicado: (2017)

Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study
por: Domachevsky, Liran, et al.
Publicado: (2017)

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study
por: Moore, Assaf, et al.
Publicado: (2018)

Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using (18) F-FDG PET-CT imaging. A prospective clinical study
por: Goldberg, Natalia, et al.
Publicado: (2012)

Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018)

Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer
por: Zlotnik, Oran, et al.
Publicado: (2021)

Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma
por: Haddad, Riad, et al.
Publicado: (2022)

The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer
por: Kundel, Yulia, et al.
Publicado: (2023)

Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy
por: Wasserberg, Nir, et al.
Publicado: (2014)

Lost in space(s): multimodal neuroimaging of disorientation along the Alzheimer’s disease continuum
por: Peters-Founshtein, Gregory, et al.
Publicado: (2023)

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study
por: Sarfaty, Michal, et al.
Publicado: (2017)

Effect of steroid treatment on the diagnostic yield of baseline (18)f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma
por: Geiger, Karyn Revital, et al.
Publicado: (2022)

Blind spots at oncological CT: lessons learned from PET/CT
por: Sosna, Jacob, et al.
Publicado: (2012)

Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
por: Eshet, Yael, et al.
Publicado: (2021)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

(18)F‐FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma
por: Wang, Shuohua, et al.
Publicado: (2023)

Prediction of pathological response after neoadjuvant chemotherapy using baseline FDG PET heterogeneity features in breast cancer
por: Oliveira, Carla, et al.
Publicado: (2023)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
por: Deantonio, Letizia, et al.
Publicado: (2018)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with (18)F-FDG PET Radiomics Based Machine Learning Classification
por: Beukinga, Roelof J., et al.
Publicado: (2022)

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
por: Reyes Marlés, Rafael Hernando, et al.
Publicado: (2021)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction
por: Fencl, Pavel, et al.
Publicado: (2016)

The utility of PET/CT in large vessel vasculitis
por: Ben Shimol, Jennifer, et al.
Publicado: (2020)

Diffusion-weighted MRI and (18)F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2021)

Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
por: Kundel, Yulia, et al.
Publicado: (2020)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

The impact of baseline (18)F-FDG PET-CT on the management and outcome of patients with gastric cancer
por: Foley, Kieran G, et al.
Publicado: (2022)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

Predictive value of clinical and (18)F-FDG-PET/CT derived imaging parameters in patients undergoing neoadjuvant chemoradiation for esophageal squamous cell carcinoma
por: Marr, Lisa, et al.
Publicado: (2022)

The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Management of Nocardiosis: A Retrospective Study and Review of the Literature
por: Margalit, Ili, et al.
Publicado: (2021)

Measuring Visceral Adipose Tissue Metabolic Activity in Sleep Apnea Utilizing Hybrid (18)F-FDG PET/MRI: A Pilot Study
por: Kundel, Vaishnavi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7q1h50cp51ocp8vn0bgsr6cgfa